EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $239,000 | -29.7% | 7,705 | -6.9% | 0.01% | -18.2% |
| Q1 2022 | $340,000 | -5.6% | 8,280 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $360,000 | -15.9% | 8,280 | -3.2% | 0.01% | -38.9% |
| Q3 2021 | $428,000 | -20.6% | 8,552 | 0.0% | 0.02% | -18.2% |
| Q2 2021 | $539,000 | -37.8% | 8,552 | -8.3% | 0.02% | -42.1% |
| Q1 2021 | $867,000 | +3.7% | 9,330 | 0.0% | 0.04% | 0.0% |
| Q4 2020 | $836,000 | -25.9% | 9,330 | -14.5% | 0.04% | -34.5% |
| Q3 2020 | $1,128,000 | +21.9% | 10,918 | -6.6% | 0.06% | +18.4% |
| Q2 2020 | $925,000 | +16.9% | 11,692 | -14.5% | 0.05% | +2.1% |
| Q1 2020 | $791,000 | +25.6% | 13,669 | +17.1% | 0.05% | +60.0% |
| Q4 2019 | $630,000 | -4.4% | 11,677 | -7.4% | 0.03% | -11.8% |
| Q3 2019 | $659,000 | +7.9% | 12,611 | -0.2% | 0.03% | +3.0% |
| Q2 2019 | $611,000 | +772.9% | 12,642 | +806.9% | 0.03% | +725.0% |
| Q1 2019 | $70,000 | +52.2% | 1,394 | +78.0% | 0.00% | +33.3% |
| Q4 2018 | $46,000 | +7.0% | 783 | +19.4% | 0.00% | +50.0% |
| Q3 2018 | $43,000 | – | 656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 962,696 | $31,615,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 486,609 | $15,979,000 | 0.98% |
| LOMBARDIA CAPITAL PARTNERS LLC | 272,465 | $8,948,000 | 0.92% |
| Matarin Capital Management, LLC | 227,687 | $7,477,241,000 | 0.84% |
| Campbell & CO Investment Adviser LLC | 6,434 | $211,000 | 0.65% |
| RICE HALL JAMES & ASSOCIATES, LLC | 390,100 | $12,811,000 | 0.65% |
| Nine Chapters Capital Management LLC | 10,100 | $332,000 | 0.56% |
| Pine River Capital Management L.P. | 284,180 | $9,332,000 | 0.34% |
| Capital Impact Advisors, LLC | 24,637 | $809,000 | 0.34% |
| GLENMEDE TRUST CO NA | 1,470,747 | $48,297,000 | 0.26% |